Search AAGH
America Great Health
OTC · CIK 1098009
Last close0
Daily change+0.00 (0.00%)
10 Years gain-97.14%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
AAGH · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 0630
Fundamental
55.2Momentum
48.0Acceleration
48.0Confidence
86.0Annual Revenue13
Quarterly Revenue35
Annual CFO14
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth13.9 / 25
Quality16.3 / 25
Capital Efficiency20.0 / 20
Balance Sheet5.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 19.4393 percentage points.
Key Metrics
Revenue Growth TTM-24.92%OK
Revenue CAGR 3Y55.27%OK
Gross Margin70.35%OK
Operating Margin-114.7%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFO-17.9xOK
Diluted Share Growth 1Y0.07%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Jun 30, 2025 | $391,743.00 | $339,121.00 | -$382,935.00 | -$332,862.00 | n/a | 86.57% | -97.75% | n/a | n/a | 21.14B |
| 2025 FY Jun 30, 2024 | $294,670.00 | $169,750.00 | -$782,700.00 | -$615,627.00 | n/a | 57.61% | -265.62% | n/a | n/a | 21.12B |
| 2024 FY Jun 30, 2023 | $204,308.00 | $168,588.00 | -$492,644.00 | -$389,809.00 | -$434,229.00 | 82.52% | -241.13% | -212.54% | n/a | 21.09B |
| 2023 FY Jun 30, 2022 | $104,648.00 | -$1.48M | -$4.73M | -$1.48M | -$1.50M | -1,417.9% | -4,523.83% | -1,430.23% | n/a | n/a |
| 2022 FY Jun 30, 2021 | $195,671.00 | $51,353.00 | -$243,560.00 | -$329,241.00 | -$341,912.00 | 26.24% | -124.47% | -174.74% | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $314,950.00 | sum latest 4 fiscal quarters Revenue | OK | 0001185185-26-003308, 0001185185-26-002331 |
| Revenue Growth TTM | -24.92% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001185185-26-003308, 0001185185-26-002331 |
| Revenue CAGR 3Y | 55.27% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001185185-26-001339 |
| Revenue CAGR 5Y | 134.93% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001185185-26-001339 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001185185-26-001339 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001185185-26-003308, 0001185185-26-002331 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 70.35% | Gross Profit / Revenue | OK | 0001185185-26-003308, 0001185185-26-002331 |
| Operating Margin | -114.7% | Operating Income / Revenue | OK | 0001185185-26-003308, 0001185185-26-002331 |
| CFO / Net Income | -0.19x | CFO / Net Income | OK | 0001185185-26-003308, 0001185185-26-002596 |
| Net Debt / CFO | -17.9x | Net Debt / CFO | OK | 0001185185-26-003308, 0001185185-26-002596 |
| Current Ratio | 0.06x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.01x | (Cash + Short-term Investments) / Total Debt | OK | 0001185185-26-003308 |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001185185-26-003308, 0001185185-26-002331 |